| 集中隔离医学观察场所感染防控专家共识 |
| |
| 引用本文： | 李春辉,蔡虻,陈萍,陈青,陈昆,常卫,陈修文,邓子德,邓志红,付强,付元瑜,高晓东,贺繁荣,贺雄,胡必杰,胡世雄,黄丽菊,黄勋,江育玲,李卫光,梁宁,刘思娣,刘园,刘运喜,柳恒卓,陆群,马乐龙,马文晖,马志鑫,茅一萍,欧阳娜,乔甫,任南,孙守红,田芳芳,童德军,王云,吴红梅,颜小利,杨帆,杨红晖,姚希,曾翠,曾赛男,张兵,张浩军,张晓霞,张新蕾,张永栋,周鹏程,宗志勇,李六亿,吴安华,中华预防医学会医院感染控制分会,中国医院协会医院感染管理专业委员会和中国感染控制杂志编辑委员会联合发布.集中隔离医学观察场所感染防控专家共识[J].中国感染控制杂志,2022,21(6):511-523. |
| |
| 作者姓名： | 李春辉 蔡虻 陈萍 陈青 陈昆 常卫 陈修文 邓子德 邓志红 付强 付元瑜 高晓东 贺繁荣 贺雄 胡必杰 胡世雄 黄丽菊 黄勋 江育玲 李卫光 梁宁 刘思娣 刘园 刘运喜 柳恒卓 陆群 马乐龙 马文晖 马志鑫 茅一萍 欧阳娜 乔甫 任南 孙守红 田芳芳 童德军 王云 吴红梅 颜小利 杨帆 杨红晖 姚希 曾翠 曾赛男 张兵 张浩军 张晓霞 张新蕾 张永栋 周鹏程 宗志勇 李六亿 吴安华 中华预防医学会医院感染控制分会 中国医院协会医院感染管理专业委员会和中国感染控制杂志编辑委员会联合发布 |
| |
| 作者单位： | 1.中南大学湘雅医院 全国医院感染监控管理培训基地 国家老年疾病临床医学研究中心(湘雅医院);2.北京医院，北京 10073;3.四川省成都市公共卫生临床医疗中心;4.湖南中医药大学第一附属医院;5.湖南医药学院第一附属医院;6.江西省儿童医院;7.中山大学附属第三医院;8.湖南省疾病预防控制中心;9.国家卫生健康委卫生发展研究中心，北京 100044;10.怀化市第一人民医院;11.复旦大学附属中山医院，上海 200032;12.北京市疾病预防控制中心，北京 100013;13.三亚市疾病预防控制中心;14.湖南省人民医院;15.山东第一医科大学附属省立医院;16.河南省人民医院;17.邵阳学院附属第一医院;18.中国人民解放军总医院第一医学中心，北京 100039;19.中南大学湘雅二医院;20.浙江大学医学院附属第二医院;21.湖南省儿童医院;22.首都医科大学宣武医院，北京 100053;23.安徽省卫生健康委员会综合监督所;24.徐州医科大学附属医院;25.四川大学华西医院;26.国家卫生健康委卫生健康监督中心，北京 100007;27.湖南省中医药研究院附属医院;28.安徽省第二人民医院;29.温州市人民医院;30.复旦大学附属华山医院，上海 200040;31.长沙市中心医院;32.北京大学第一医院，北京 100034;33.中南大学湘雅三医院;34.江苏省卫生监督所;35.甘肃省第二人民医院;36.长治医学院附属和平医院;37.北京市红十字会急诊抢救中心，北京 100192;38.青海大学附属医院 |
| |
| 摘 要： | 为科学指导新型冠状病毒肺炎(以下简称新冠肺炎, COVID-19)疫情期间集中隔离医学观察场所内感染防控工作, 在早期有效识别感染者的同时, 有效避免集中隔离医学观察场所内的交叉感染, 中华预防医学会医院感染控制分会、中国医院协会医院感染管理专业委员会、中国感染控制杂志编辑部组织有关专家共同制定本共识。本共识适用于确诊病例、疑似病例、无症状感染者的密切接触者、密切接触者的密切接触者, 以及入境人员或其他根据防控工作需要"应隔尽隔"人员开展集中隔离医学观察时所设置的集中隔离医学观察场所, 指导其工作人员正确做好个人防护及防止感染传播工作, 避免发生场所内感染及传播。本共识借鉴医疗机构内新型冠状病毒感染防控的基本原则、文件规范, 结合集中隔离医学观察场所的特点与实际工作情况, 对不同区域工作人员、工作环节开展新型冠状病毒传播的风险评估, 并据此对集中隔离医学观察场所的感染防控组织架构、选址布局、人员防护、人员闭环管理、清洁消毒、环境核酸监测、人员健康监测、职业暴露处理及交叉感染判定原则等感控相关工作给予指导。
|
| 关 键 词： | 新型冠状病毒 新型冠状病毒肺炎 集中隔离观察 感染防控 传播 |
| 收稿时间： | 2022/5/6 0:00:00 |
Expert consensus on infection prevention and control in centralized isolation sites for medical observation |
| |
| Institution: | 1.National Training Center of Healthcare-associated Infection Management, National Clinical Research Center for Geriatric Disorders [Xiangya Hospital], Xiangya Hospital, Central South University, Changsha 410008, China;2.Beijing Hospital, Beijing 100730, China;3.Public Health Clinical Center of Chengdu of Sichuan Province, Chengdu 610000, China;4.The First Hospital of Hunan University of Chinese Medicine, Changsha 410021, China;5.The First Affiliated Hospital of Hunan University of Medicine, Huaihua 418000, China;6.Jiangxi Provincial Children''s Hospital, Nanchang 330006, China;7.The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou 510630, China;8.Hunan Provincial Center for Disease Control and Prevention, Changsha 410028, China;9.National Health Development Research Center, Beijing 100044, China;10.Huaihua First People''s Hospital, Huaihua 418000, China;11.Zhongshan Hospital Affiliated to Fudan University, Shanghai 200032, China;12.Beijing Center for Disease Prevention and Control, Beijing 100013, China;13.Sanya Center for Disease Prevention and Control, Sanya 572000, China;14.Hunan Provincial People''s Hospital, Changsha 410005, China;15.Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan 250021, China;16.Henan Provincial People''s Hospital, Zhengzhou 450003, China;17.The First Hospital Affiliated to Shaoyang College, Shaoyang 422001, China;18.The First Medical Center, Chinese PLA General Hospital, Beijing 100039, China;19.The Second Xiangya Hospital of Central South University, Changsha 410011, China;20.The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou 310009, China;21.Hunan Children''s Hospital, Changsha 410007, China;22.Xuanwu Hospital, Capital Medical University, Beijing 100053, China;23.General Supervision Agency of Health Commission of Anhui Pro-vince, Hefei 230002, China;24.Affiliated Hospital of Xuzhou Medical University, Xuzhou 221006, China;25.West China Hospital, Sichuan University, Chengdu 610041, China;26.The Center of Health Supervision National Health Commission of the People''s Republic of China, Beijing 100007, China;27.Hunan Academy of Traditional Chinese Medicine Affili-ated Hospital, Changsha 410006, China;28.Anhui No.2 Provincial People''s Hospital, Hefei 230012, China;29.Wenzhou People''s Hospital, Wenzhou 325000, China;30.Huashan Hospital Affiliated to Fudan University, Shanghai 200040, China;31.Changsha Central Hospital, Changsha 410018, China;32.Peking University First Hospital, Beijing 100034, China;33.The Third Xiangya Hospital of Central South University, Changsha 410013, China;34.Jiangsu Provincial Health Supervision Institute, Nanjing 210009, China;35.Second Provincial People''s Hospital of Gansu, Lanzhou 730000, China;36.Heping Hospital Affiliated to Changzhi Medical College, Changzhi 046000, China;37.Beijing Red Cross Emergency Medical Rescue Center, Beijing 100192, China;38.Qinghai University Affiliated Hospital, Xining 810001, China |
| |
| Abstract: | In order to scientifically guide the infection prevention and control in centralized isolation sites for medical observation during the outbreak of coronavirus disease 2019 (COVID-19), effectively avoid cross infection while identifying infected person at an early stage in centralized isolation sites for medical observation, Healthcare-associa-ted Infection Control Branch of Chinese Preventive Medicine Association, Healthcare-associated Infection Management Committee of Chinese Hospital Association, and Editorial Office of Chinese Journal of Infection Control jointly organize experts to formulate this consensus. This consensus is applicable to centralized isolation sites for medical observation of close contacts of confirmed COVID-19 cases, suspected cases and asymptomatic infected person, se-condary contacts, entry personnel, or other personnel who "should be isolated" according to the needs of prevention and control work, instruct staff to properly perform personal protection and prevent infection transmission, so as to avoid infection and spread within the site. This consensus draws on the basic principles and document specifications for the prevention and control of COVID-19 in medical institutions, and combines the characteristics and actual working conditions of centralized isolation sites for medical observation to carry out risk assessment of transmission for staff in different regions and different work links. Based on assessment, guidance will be given to infection control-related work, including organizational structure of infection prevention and control, site selection and layout, personnel protection, personnel closed-loop management, cleaning and disinfection, environmental monitoring of nucleic acid, personnel health monitoring, occupational exposure treatment, and judgement principle of cross infection. |
| |
| Keywords: | SARS-CoV-2 coronavirus disease 2019 centralized isolation for medical observation infection prevention and control transmission |
|
| 点击此处可从《中国感染控制杂志》浏览原始摘要信息 |
| 点击此处可从《中国感染控制杂志》下载免费的PDF全文 |
|
